Basilea Pharmaceutica AG (BSLN) — Financial Flexibility Index
Basilea Pharmaceutica AG (BSLN) has a Financial Flexibility Index of 0.27x as of December 2025. Free cash flow of CHF41.33 Million (operating CF CHF39.03 Million minus capex CHF2.30 Million) represents 0% of total liabilities (CHF154.06 Million). Check Basilea Pharmaceutica AG (BSLN) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Basilea Pharmaceutica AG Financial Flexibility Index (2002–2025)
Historical Financial Flexibility Index trend for Basilea Pharmaceutica AG across 24 annual periods. For the full cash flow conversion analysis, see Basilea Pharmaceutica AG (BSLN) cash conversion ratio.
Annual Financial Flexibility Index for Basilea Pharmaceutica AG (2002–2025)
Year-by-year free cash flow to debt coverage for Basilea Pharmaceutica AG. Explore BSLN debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CHF) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.42x | CHF64.71 Million | CHF62.09 Million | CHF154.06 Million | ▼ -2.4% |
| 2024 | 0.43x | CHF76.07 Million | CHF74.36 Million | CHF176.76 Million | ▲ +416.3% |
| 2023 | 0.08x | CHF15.28 Million | CHF14.24 Million | CHF183.29 Million | ▲ +94.4% |
| 2022 | 0.04x | CHF10.36 Million | CHF7.06 Million | CHF241.56 Million | ▲ +142.1% |
| 2021 | -0.10x | CHF-31.16 Million | CHF-32.02 Million | CHF305.87 Million | ▲ +34.8% |
| 2020 | -0.16x | CHF-51.87 Million | CHF-54.13 Million | CHF331.84 Million | ▲ +22.5% |
| 2019 | -0.20x | CHF-63.43 Million | CHF-63.84 Million | CHF314.43 Million | ▲ +10.8% |
| 2018 | -0.23x | CHF-78.79 Million | CHF-79.21 Million | CHF348.44 Million | ▼ -550.1% |
| 2017 | 0.05x | CHF19.73 Million | CHF19.01 Million | CHF392.61 Million | ▲ +124.4% |
| 2016 | -0.21x | CHF-74.61 Million | CHF-75.00 Million | CHF362.76 Million | ▼ -18.2% |
| 2015 | -0.17x | CHF-66.77 Million | CHF-67.78 Million | CHF383.88 Million | ▲ +50.6% |
| 2014 | -0.35x | CHF-70.21 Million | CHF-71.46 Million | CHF199.45 Million | ▼ -38.1% |
| 2013 | -0.26x | CHF-58.37 Million | CHF-59.47 Million | CHF228.88 Million | ▼ -146.0% |
| 2012 | 0.55x | CHF149.50 Million | CHF148.17 Million | CHF269.84 Million | ▲ +158.9% |
| 2011 | -0.94x | CHF-78.85 Million | CHF-82.38 Million | CHF83.82 Million | ▼ -192.7% |
| 2010 | 1.01x | CHF107.88 Million | CHF106.64 Million | CHF106.30 Million | ▲ +198.0% |
| 2009 | -1.04x | CHF-112.75 Million | CHF-114.51 Million | CHF108.88 Million | ▼ -9.0% |
| 2008 | -0.95x | CHF-121.95 Million | CHF-127.17 Million | CHF128.38 Million | ▼ -65.6% |
| 2007 | -0.57x | CHF-72.46 Million | CHF-78.99 Million | CHF126.34 Million | ▲ +26.5% |
| 2006 | -0.78x | CHF-70.84 Million | CHF-72.47 Million | CHF90.78 Million | ▼ -292.3% |
| 2005 | 0.41x | CHF35.58 Million | CHF34.38 Million | CHF87.69 Million | ▲ +113.5% |
| 2004 | -3.01x | CHF-63.76 Million | CHF-64.20 Million | CHF21.18 Million | ▼ -5.0% |
| 2003 | -2.87x | CHF-47.98 Million | CHF-52.42 Million | CHF16.73 Million | ▼ -74.3% |
| 2002 | -1.65x | CHF-41.35 Million | CHF-64.07 Million | CHF25.13 Million | — |